Patients with stable COPD and infrequent exacerbations can de-escalate from triple therapy to dual bronchodilator therapy with minimal change to lung function and no change to exacerbation rates. According to research presented at ATS 2018 and published in the American Journal of Respiratory and Critical Care Medicine, removing the inhaled corticosteroid from triple therapy was ...
Step down in therapy suits stable COPD
By Mardi Chapman
22 May 2018